Eosinophil Count Changes and Glycemic Control: A Retrospective Cohort Study in Adults with Diabetes
- 1Brigham and Women's Hospital
Abstract
Glycemic control is key to prevention of complications of diabetes. Although eosinophils have been implicated in metabolic regulation, most human studies have been cross-sectional and have yielded inconsistent findings.
We conducted a retrospective cohort study of adults with uncontrolled diabetes receiving primary care at Mass General Brigham. We evaluated the relationship between eosinophil count and HbA1c over one year, adjusting for demographic, socioeconomic, and clinical covariates.
Among 21,447 patients included in the study, eosinophil count increased by a mean of 2.6 cells/L (SD 157.2 cells/L) and HbA1c decreased by a mean of 0.82% (SD 2.09%) during follow-up. Increases in eosinophil count were associated with reductions in HbA1c (parameter estimate -0.366 per 1,000 cells/L; 95% CI -0.526 to -0.206; P < 0.001), whereas baseline eosinophil count was not significantly associated with HbA1c changes. The association remained significant in a sensitivity analysis excluding systemic glucocorticoid users.
Increases in eosinophil count were associated with improved glycemic control in adults with diabetes, whereas baseline eosinophil count was not. These findings extend prior cross-sectional observations and suggest that changes in eosinophils may represent a biomarker of glycemic improvement. Further prospective studies are needed to determine whether this relationship reflects underlying immune-metabolic mechanisms or treatment-related changes.
Related
- Chronic Proton Pump Inhibitor Use and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study
- Online co-care management and glycemic control in patients with type 2 diabetes mellitus: A propensity score-matched retrospective cohort study
- C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide
- Changes in CGM-Derived Glycemic Metrics and Triglyceride-Glucose Index During Ramadan in Adults With Type 2 Diabetes Using Real-Time Continuous Glucose Monitoring
- Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study
BibTeX
@misc{banerjee2026eosinophil,
title = {{Eosinophil Count Changes and Glycemic Control: A Retrospective Cohort Study in Adults with Diabetes}},
author = {S. Banerjee and M. Shubina and F. Morrison and A. Turchin},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.26365690},
url = {https://www.medrxiv.org/content/10.64898/2026.10.15.26365690v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Eosinophil Count Changes and Glycemic Control: A Retrospective Cohort Study in Adults with Diabetes
AU - S. Banerjee
AU - M. Shubina
AU - F. Morrison
AU - A. Turchin
PY - 2026
DA - 2026/10/15
PB - medRxiv
DO - 10.64898/2026.10.15.26365690
UR - https://www.medrxiv.org/content/10.64898/2026.10.15.26365690v1
AB - Glycemic control is key to prevention of complications of diabetes. Although eosinophils have been implicated in metabolic regulation, most human studies have been cross-sectional and have yielded inconsistent findings. We conducted a retrospective cohort study of adults with uncontrolled diabetes receiving primary care at Mass General Brigham. We evaluated the relationship between eosinophil count and HbA1c over one year, adjusting for demographic, socioeconomic, and clinical covariates. Among 21,447 patients included in the study, eosinophil count increased by a mean of 2.6 cells/L (SD 157.2 cells/L) and HbA1c decreased by a mean of 0.82% (SD 2.09%) during follow-up. Increases in eosinophil count were associated with reductions in HbA1c (parameter estimate -0.366 per 1,000 cells/L; 95% CI -0.526 to -0.206; P < 0.001), whereas baseline eosinophil count was not significantly associated with HbA1c changes. The association remained significant in a sensitivity analysis excluding systemic glucocorticoid users. Increases in eosinophil count were associated with improved glycemic control in adults with diabetes, whereas baseline eosinophil count was not. These findings extend prior cross-sectional observations and suggest that changes in eosinophils may represent a biomarker of glycemic improvement. Further prospective studies are needed to determine whether this relationship reflects underlying immune-metabolic mechanisms or treatment-related changes.
ER -